NCT07719660 Wearable Blood-Pressure Monitoring Comparison Study
| NCT ID | NCT07719660 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Technische Universität Dresden |
| Condition | Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-07-20 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-07-20 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the accuracy, clinical applicability, and usability of different wearable blood pressure monitoring methods integrated in wearable devices, such as smartwatches, in hospitalized patients. The study evaluates novel photoplethysmography (PPG)-based and wrist-oscillometric blood pressure measurement methods against established clinical reference methods (upper-arm cuff measurements on the general ward and invasive arterial blood pressure monitoring (A-line) in the intensive care unit). The main questions the study aims to answer are: * Can novel blood pressure monitoring methods suitable for integration into wearable devices achieve clinically acceptable agreement with established reference measurements? * How does the performance of calibration-dependent wearable devices change over time following calibration? * How does the performance of the investigated methods compare with each other? * How do the investigated methods perform for patients with different pre-existing conditions ? To answer these questions, participants will undergo: * blood pressure measurements using different wearable devices based on PPG and wrist oscillometry * standardized reference blood pressure measurements using an upper-arm cuff (general ward) or an existing invasive arterial line (intensive care unit) * repeated measurements over three consecutive days on the general ward to assess calibration stability and measurement reproducibility,
Eligibility Criteria
Inclusion Criteria: * Blood pressure measurements can be performed on at least one arm, for example no amputation, dialysis shunt, or obstructive dressing * Ability to understand the study information and provide written informed consent * For participants in the intensive care unit: an arterial line placed for clinical reasons Exclusion Criteria: * Wrist circumference exceeds the size range of the investigated wearable devices * Physical or medical conditions preventing placement of the wearable devices, including relevant skin lesions, wounds, severe edema, or patient restraint * Inability to provide written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07719660 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 85 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07719660 currently recruiting?
Yes, NCT07719660 is actively recruiting participants. Contact the research team at moritz.herzog@ukdd.de for enrollment information.
Where is the NCT07719660 trial being conducted?
This trial is being conducted at Dresden, Germany, Florence, Italy.
Who is sponsoring the NCT07719660 clinical trial?
NCT07719660 is sponsored by Technische Universität Dresden. The trial plans to enroll 120 participants.